These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 2527093

  • 21. Lp(a) phenotyping by immunoblotting with polyclonal and monoclonal antibodies.
    Kraft HG, Dieplinger H, Hoye E, Utermann G.
    Arteriosclerosis; 1988; 8(3):212-6. PubMed ID: 2967073
    [Abstract] [Full Text] [Related]

  • 22. Enzyme-linked immunoassay for Lp[a].
    Fless GM, Snyder ML, Scanu AM.
    J Lipid Res; 1989 May; 30(5):651-62. PubMed ID: 2527286
    [Abstract] [Full Text] [Related]

  • 23. Detection of IgG-bound lipoprotein(a) immune complexes in patients with coronary heart disease.
    Wang J, Qiang H, Zhang C, Liu X, Chen D, Wang S.
    Clin Chim Acta; 2003 Jan; 327(1-2):115-22. PubMed ID: 12482626
    [Abstract] [Full Text] [Related]

  • 24. Measurement of Lp(a) with a two-step monoclonal competitive sandwich ELISA method.
    Morikawa W, Iki R, Terano T, Funatsu A, Sugiuchi H, Uji Y, Okabe H.
    Clin Biochem; 1995 Jun; 28(3):269-75. PubMed ID: 7554245
    [Abstract] [Full Text] [Related]

  • 25. Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease.
    Koren E, Corder C, Mueller G, Centurion H, Hallum G, Fesmire J, McConathy WD, Alaupovic P.
    Atherosclerosis; 1996 Apr 26; 122(1):105-15. PubMed ID: 8724117
    [Abstract] [Full Text] [Related]

  • 26. Determination of lipoprotein(a): evaluation of three methods.
    März W, Siekmeier R, Gross W, Kostner GM.
    Eur J Clin Chem Clin Biochem; 1993 May 26; 31(5):295-302. PubMed ID: 8357938
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Attenuation of immunologic reactivity of lipoprotein(a) by thiols and cysteine-containing compounds. Structural implications.
    Scanu AM, Pfaffinger D, Fless GM, Makino K, Eisenbart J, Hinman J.
    Arterioscler Thromb; 1992 Apr 26; 12(4):424-9. PubMed ID: 1532745
    [Abstract] [Full Text] [Related]

  • 29. Association of Lp(a) rather than integrally-bound apo(a) with triglyceride-rich lipoproteins of human subjects.
    Marcoux C, Lussier-Cacan S, Davignon J, Cohn JS.
    Biochim Biophys Acta; 1997 Jun 23; 1346(3):261-74. PubMed ID: 9219911
    [Abstract] [Full Text] [Related]

  • 30. Quantification of human apolipoprotein E in plasma and lipoprotein subfractions by a non-competitive enzyme immunoassay.
    Koffigan M, Kora I, Clavey V, Bard JM, Chapman J, Fruchart JC.
    Clin Chim Acta; 1987 Mar 30; 163(3):245-56. PubMed ID: 3581471
    [Abstract] [Full Text] [Related]

  • 31. Correlation of apolipoprotein(a) isoproteins with Lp(a) density and distribution in fasting plasma.
    Reblin T, Rader DJ, Beisiegel U, Greten H, Brewer HB.
    Atherosclerosis; 1992 Jun 30; 94(2-3):223-32. PubMed ID: 1385958
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Development of new enzyme-linked immunosorbent assay for oxidized lipoprotein(a) by using purified human oxidized lipoprotein(a) autoantibodies as capture antibody.
    Wang J, Zhang C, Gong J, Zhu Y, Fu L, Wang X, Li K.
    Clin Chim Acta; 2007 Oct 30; 385(1-2):73-8. PubMed ID: 17719023
    [Abstract] [Full Text] [Related]

  • 34. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
    Hartgens F, Rietjens G, Keizer HA, Kuipers H, Wolffenbuttel BH.
    Br J Sports Med; 2004 Jun 30; 38(3):253-9. PubMed ID: 15155420
    [Abstract] [Full Text] [Related]

  • 35. Dissociation-enhanced lanthanide fluorescence immunoassay of lipoprotein(a) in serum.
    Jürgens G, Hermann A, Aktuna D, Petek W.
    Clin Chem; 1992 Jun 30; 38(6):853-9. PubMed ID: 1534526
    [Abstract] [Full Text] [Related]

  • 36. Lipoprotein(a) is increased in triglyceride-rich lipoproteins in men with coronary heart disease, but does not change acutely following oral fat ingestion.
    Hoppichler F, Kraft HG, Sandholzer C, Lechleitner M, Patsch JR, Utermann G.
    Atherosclerosis; 1996 Apr 26; 122(1):127-34. PubMed ID: 8724119
    [Abstract] [Full Text] [Related]

  • 37. Measurement of oxidation in plasma Lp(a) in CAPD patients using a novel ELISA.
    Podrez EA, O'Neil J, Salomon RG, Schreiber MJ, Hoff HF.
    Kidney Int; 1998 Aug 26; 54(2):637-45. PubMed ID: 9690232
    [Abstract] [Full Text] [Related]

  • 38. Characterization of monoclonal antibodies to apolipoprotein (a) and development of a chemiluminescent assay for phenotyping apolipoprotein (a) isomorphs.
    Théolis R, Breckenridge WC.
    J Immunol Methods; 1994 Jun 03; 172(1):43-58. PubMed ID: 7515934
    [Abstract] [Full Text] [Related]

  • 39. Plasma Lp-PLA(2) mass and apoB-lipoproteins that carry Lp-PLA(2) decrease after sodium.
    Constantinides A, Kerstens MN, Dikkeschei BD, van Pelt LJ, Tellis CC, Tselepis AD, Dullaart RP.
    Eur J Clin Invest; 2012 Nov 03; 42(11):1235-43. PubMed ID: 22957745
    [Abstract] [Full Text] [Related]

  • 40. Competitive enzyme-linked immunosorbent assay (ELISA) for the quantitation of apolipoprotein A-I using a monoclonal antibody.
    Bojanovski M, Gregg RE, Wilson DM, Brewer HB.
    Clin Chim Acta; 1988 Dec 15; 178(2):159-69. PubMed ID: 3149556
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.